Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Yield10 Bioscience Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
YTEN
Nasdaq
8731
https://www.yield10bio.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Yield10 Bioscience Inc
Yield10 Bioscience Announces 1-for-24 Reverse Stock Split
- May 1st, 2024 12:30 pm
Yield10 Bioscience, Inc. (NASDAQ:YTEN) Q4 2023 Earnings Call Transcript
- Apr 5th, 2024 12:53 pm
Q4 2023 Yield10 Bioscience Inc Earnings Call
- Apr 2nd, 2024 10:34 am
Yield10 Bioscience Announces Fourth Quarter and Full Year 2023 Financial Results
- Apr 1st, 2024 8:01 pm
Yield10 Bioscience to Announce Fourth Quarter and Full Year 2023 Financial Results and Host a Conference Call on Monday, April 1, 2024
- Mar 28th, 2024 8:01 pm
Yield10 Bioscience Announces that the Plant Biosafety Office of the Canadian Food Inspection Agency has Cleared Genome-edited E3902 Camelina for Planting in Canada
- Mar 26th, 2024 12:29 pm
USDA-APHIS Determines that Yield10 Bioscience’s Omega-3 Camelina Varieties May Be Planted and Bred in the United States
- Mar 21st, 2024 12:29 pm
Yield10 Bioscience Reports that Proprietary Varieties of Winter Camelina Show Tolerance to Commonly Used Herbicides in First Field Tests
- Feb 29th, 2024 1:31 pm
Yield10 Bioscience Grants Global License to VISION Bioenergy Oilseeds for Herbicide Tolerant Camelina Cultivated for the Production of Biofuel Feedstock
- Feb 14th, 2024 2:00 pm
Yield10 Bioscience Provides an Update on its Omega-3 Camelina Program
- Feb 7th, 2024 10:40 pm
Yield10 Bioscience Files Request for Regulatory Status Review with USDA-APHIS for Camelina Designed to Produce the EPA and DHA Components of Omega-3 Oil
- Jan 8th, 2024 1:31 pm
Yield10 Bioscience, Inc. (NASDAQ:YTEN) Q3 2023 Earnings Call Transcript
- Nov 16th, 2023 2:12 pm
USDA-APHIS Determines that Yield10 Bioscience’s Stacked Herbicide Tolerant Camelina May Be Planted and Bred in the United States
- Nov 15th, 2023 1:32 pm
USDA-APHIS Determines that Yield10 Bioscience’s Glufosinate Tolerant Camelina May Be Planted and Bred in the United States
- Nov 15th, 2023 1:31 pm
Yield10 Bioscience Announces Third Quarter 2023 Financial Results
- Nov 14th, 2023 9:01 pm
Yield10 Bioscience to Announce Third Quarter 2023 Financial Results and Host a Conference Call on Tuesday, November 14, 2023
- Nov 8th, 2023 1:31 pm
Yield10 Bioscience and BioMar Aim to Grow Fish Oil on Land
- Oct 31st, 2023 12:31 pm
Yield10 Bioscience Exercises Option to Finalize an Exclusive, Global Commercial License to Advanced Omega-3 Camelina Technology from Rothamsted Research
- Oct 18th, 2023 12:31 pm
Yield10 Bioscience Provides Update on Recent Advancements in the Development of Elite Herbicide Tolerant Camelina
- Oct 11th, 2023 12:31 pm
Yield10 Bioscience Completes Harvest of a Majority of the 2023 Winter and Spring Camelina Grain Grown Under Contract, Generating Revenue from Biofuel Production
- Oct 3rd, 2023 12:31 pm
Scroll